VCP immunoreactivity has been observed in Lewy bodies in Parkinson’s disease and dementia with Lewy bodies, in neuronal nuclear inclusions in polyglutamine diseases and intranuclear inclusion body disease, in Marinesco bodies [29], and in epidermal cells from patients with SALS [30]. This evidence concerns the gene VCP and Parkinson disease.